Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 02:13PM EST. Market open.
| Previous close | 27.08 |
| Open | 27.38 |
| Bid | 26.99 x 800 |
| Ask | 27.05 x 1000 |
| Day's range | 26.32 - 27.66 |
| 52-week range | 15.58 - 48.40 |
| Volume | |
| Avg. volume | 177,753 |
| Market cap | 719.135M |
| Beta (5Y monthly) | 1.00 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.04 |
| Earnings date | 27 Feb 2023 - 03 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 49.63 |
- Business Wire
Castle Biosciences’ Medical Director to Present at the Precision Medicine World Conference 2023
FRIENDSWOOD, Texas, January 23, 2023--Castle's medical director, Matthew Goldberg, M.D., F.A.A.D., will present at the Precision Medicine World Conference (PMWC®) 2023 on Jan. 25.
- Business Wire
Data Presentations at 2023 Winter Clinical Dermatology Conference - Hawaii® Support Clinical Value of Castle Biosciences’ Skin Cancer Test Portfolio
FRIENDSWOOD, Texas, January 17, 2023--Castle is sharing new data supporting the clinical value of their skin cancer tests at the 2023 Winter Clinical Dermatology Conference - Hawaii®.
- Business Wire
Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2022 Results
FRIENDSWOOD, Texas, January 09, 2023--Castle Biosciences today announced certain unaudited preliminary performance results for the fourth quarter and full-year ended Dec. 31, 2022.
© 2023 Yahoo. All rights reserved.
